UNSPSC 51401567: Medazepam hydrochloride

This classification denotes a benzodiazepine with the molecular formula C16H15ClN2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ETM878JC9K, chemically known as 2,3-dihydro-7-chloro-1-methyl-5-phenyl-1h-1,4-benzodiazepine but more generally known as medazepam hydrochloride, which bears US NIH Compound Identifier 4041. European Medicines Agency schedules Medazepam hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB35638.

Most nations, for tariff and trade purposes, schedule medazepam hydrochloride under HS 29339190 and SITC 51577. As of Q4 2014, MEDAZEPAM HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Medazepam hydrochloride bears US NLM identifiers UMLS ID C0035766 and NCI Concept Code C66069. SMILES: CN1CCN=C(C2C1CCC(C2)CL)C3CCCCC3.CL.

UNSPSC 51401567 Medazepam hydrochloride is a Commodity code that does not align with the state and local procurement activity currently posted under it. The recent opportunities solicited under this code are for naloxone, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products — none of which involve medazepam hydrochloride specifically. The mismatch between the code's nominal scope and the actual work being bought suggests either a coding error in how opportunities are being tagged or limited relevance of this particular code to active state and local procurement.

The three recent opportunities show activity across Florida, Texas, and Minnesota through different issuing bodies: Seminole County, Florida (IFB for naloxone and drug deactivation systems, due July 26, 2023); the Texas Health and Human Services Commission (RFI for direct-to-manufacturer prescription programs, due April 3, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance administered by the Minnesota Department of Administration (RFP for generic pharmaceuticals and OTC products, due March 26, 2026). The geographic and issuing-body spread is limited, and none of the recent solicitations target medazepam hydrochloride as a commodity. Analysts evaluating this code should verify whether procurement activity is being properly classified or whether the code genuinely sees minimal state and local use.